Li-Ling Cai

SUCI02 inhibits the erbB‐2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells

Dajun Yang, Y. Zeng, Xiao-Feng Zhu, 2006, Cancer science.